Dong-A Pharmaceutical Launches 'EVERLY' Targeting Slow-Aging Trend
A Blend of Five Key Ingredients Gaining Attention, Including NMN
On July 31, Dong-A Pharmaceutical announced the launch of its premium brand 'EVERLY' in line with the slow-aging trend.
EVERLY was developed with a focus on various ingredients that have recently drawn attention in anti-aging research, including NMN. The new product contains NMN (208 mg), resveratrol (150 mg), quercetin (250 mg), fisetin (20 mg), and betaine, among other ingredients.
This product features a dual formulation that allows consumers to take both liquid and tablet forms at once. The liquid contains a red grape flavor.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A representative from Dong-A Pharmaceutical explained, "EVERLY is a new product designed for easy daily intake based on ingredients currently of interest in the field of aging research."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.